14.8
Gilead Sciences Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
14.4
FY23:
16.1
FY24:
19.2
FY25:
18.3
(positive)
Change from FY21 to FY25
billions USD
FY21:
53.2
FY22:
48.7
FY23:
46.0
FY24:
39.8
FY25:
40.7
Total assets
Change from FY21 to FY25
billions USD
FY21:
68.0
FY22:
63.2
FY23:
62.1
FY24:
59.0
FY25:
59.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
11.6
FY22:
11.2
FY23:
11.3
FY24:
12.0
FY25:
11.8
(negative)
Change from FY21 to FY25
billions USD
FY21:
35.3
FY22:
–
FY23:
28.1
FY24:
27.7
FY25:
24.6
(positive)
Change from FY21 to FY25
billions USD
FY21:
21.1
FY22:
21.2
FY23:
22.8
FY24:
19.3
FY25:
22.7
Total liabilities & equity
billions USD
FY21:
68.0
FY22:
–
FY23:
–
FY24:
–
FY25:
–
All amounts in billions USD